Thus, HA can selectively target cancerous cells over-expressing CD44 and many studies have addressed HA-modified nanomaterials as cancer targeting moieties to enhance cancer therapy without side-effects [12,13,14,15,16]. The gene discussed is CD44; the disease is cancer.